Detalhe da pesquisa
1.
A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group Trial.
Clin Colorectal Cancer
; 17(3): 231-239.e7, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29653857
2.
Phase II randomized study of ISIS 3521 and ISIS 5132 in patients with locally advanced or metastatic colorectal cancer: a National Cancer Institute of Canada clinical trials group study.
Clin Cancer Res
; 8(7): 2188-92, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12114419